Anika Therapeutics Inc (NASDAQ: ANIK) stock suffered a major decline of -11.1% on 3/13/25. The shares closed at $15.21. Moreover, trading volume in this decline was exceptionally high at 226% of normal. The stock has been extremely weak relative to the market over the last nine months and has declined -10.7% during the last week.
Current PriceTarget Research Rating
Anika Therapeutics has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. Anika Therapeutics has a poor Appreciation Score of 26 and a very low Power Rating of 4, triggering the Lowest Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment